FDA expands treatment in nephrotic syndrome

• by Kathryn Wighton

• September 28, 2026

Risk of Injury Among Children and Youths Whose Mothers Experienced Violent Injury: A Systematic Review and

• by Marissa Fazio, Barbara Haas, Sarah Bahreinian, Sorina Andrei, Hilary K. Brown, Tharani Raveendran, Natasha Saunders

• September 11, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min

Educators weigh how to use AI without losing critical thinking

Greater productivity is not necessarily indicative of greater knowledge.

• by Julia Cipriano, MS, CMPP

• September 10, 2026

• 8 min